United Kingdom (UK) Blood Glucose Monitor Market Overview, 2028

United Kingdom (UK) Blood Glucose Monitor Market Overview, 2028

Diabetes prevalence has risen considerably in the United Kingdom during the previous two decades, owing to an increase in obesity and lifestyle changes. In addition, the country has the highest obesity rate, which is a major cause of type 2 diabetes. The rapidly increasing incidence and prevalence of diabetic patients, as well as healthcare costs, are signs of market expansion. In order to achieve a significant market share, leading manufacturers are focused on technological advances and manufacturing improved products. Many technological developments and advancements make it easier to keep blood glucose levels stable. Diabetes applications enable the adoption of lifestyle changes for the prevention and management of diabetes, the evaluation of blood glucose control quality, and insulin dose. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are additional developments that provide patients with poorly controlled diabetes with the extra support they need to improve critical outcomes, thereby improving market prospects in the coming years. Depending on individual requirements and circumstances, the National Health Service (NHS) in the United Kingdom provides partial and full funding for blood glucose monitor devices. This increases diabetic patient’s access to these critical tools. The UK healthcare system actively supports diabetes management through telehealth and remote monitoring options. This involves using blood glucose monitor devices linked to mobile apps to share data with healthcare providers, facilitate remote consultations, and make changes to treatment programmes. Wearable technology is becoming more prevalent in diabetes care in the United Kingdom. Smartwatches and fitness trackers with blood glucose monitor capabilities are becoming increasingly popular, providing extra data points and allowing for real-time glucose monitoring.

According to the research report ""United Kingdom Blood Glucose Monitor Market Overview, 2028,"" published by Bonafide Research, the United Kingdom Blood Glucose Monitor market is expected to grow with more than 7% CAGR from 2023 to 2028. The UK healthcare system prioritises evidence-based medicine, with the implementation of medical innovations based on rigorous clinical evidence and cost-effectiveness studies. To acquire general acceptance within the NHS, blood glucose monitors must demonstrate not only technological improvement but also clinical efficacy and cost-effectiveness. The United Kingdom is a centre for medical research and innovation, encouraging collaboration among universities, industry, and healthcare providers. This setting fosters the development of cutting-edge blood glucose monitoring systems with a focus on precision, accuracy, and patient usability. The UK government actively supports public health efforts, such as campaigns to raise awareness of chronic diseases such as diabetes. Blood glucose monitors play an important role in these activities, allowing people to monitor and manage their health, which aligns with the country's focus on empowering people to take care of their health. Due to factors such as geographical challenges and the COVID-19 pandemic, the UK healthcare system is increasingly embracing telemedicine and remote patient monitoring, which has accelerated demand for blood glucose monitors that seamlessly integrate with digital health platforms, enabling remote monitoring and consultations. The NHS's financial structure and reimbursement rules have a considerable impact on medical device adoption. Patients are more likely to adopt blood glucose monitors suggested by NHS recommendations or reimbursed by reimbursement programmes, impacting market dominance. Diabetes is a major driver of demand for blood glucose monitors in the United Kingdom. With a sizable diabetic population, there is a greater understanding of the significance of regular monitoring and management, fostering a strong market for these devices.

In terms of product market is divided into self-monitoring devices and continuous blood glucose monitoring devices. Continuous blood glucose monitoring devices product is expected to grow at rapid pace in United Kingdom blood glucose monitor market during the forecast period. Continuous glucose monitoring devices are automated glucose monitoring systems comprised of a tiny gadget worn on the body and held in place by an adhesive patch. The sensor portion of the device contains a cannula that is placed into the top layer of skin and checks glucose levels using samples of interstitial fluid. Sensors are linked to a transmitter, which can wirelessly transfer data to a specific mobile receiving device or smartphone. Continuous glucose monitoring devices measure blood sugar levels using glucose oxidase. The most crucial component of continuous glucose monitoring systems is the sensor. During the forecast period, technological developments to improve sensor accuracy are expected to boost segment growth. The National Service Framework (NSF) programme enhances services by establishing national standards to improve service quality and address disparities in care. In the first forum of its sort, the Association of British HealthTech Industries (ABHI) launched a diabetic area, allowing diabetes technology businesses to collaborate. The ABHI group is for any health technology business interested in diabetes treatment, including CGMs, insulin pumps, and apps. Such benefits are expected to boost category growth during the predicted period.

Based on end user segment market is bifurcated into hospitals, home care, and diagnostic centers. Home care end user segment is expected to grow at significant pace in United Kingdom blood glucose monitor market in the upcoming time frame. Technological improvements have resulted in the creation of blood glucose monitors that are user-friendly, accurate, and less intrusive. These gadgets are intended for use at home by individuals, allowing them to conveniently monitor their glucose levels without the need for frequent visits to healthcare facilities. Home blood glucose monitoring allows diabetic individuals to take an active role in managing their condition. Regular monitoring promotes a greater understanding and awareness of how their lifestyle choices affect their glucose levels, resulting in better self-management and adherence to treatment recommendations. The UK provides a favourable regulatory environment for home-use medical devices, ensuring the safety and efficacy of self-monitoring blood glucose monitors. This allows the introduction of novel gadgets into the market, particularly for diabetic patients at home. Diabetes prevalence is significantly increasing in United Kingdom and is expected to drive the demand for blood glucose monitor in United Kingdom.

Considered in this report:
• Geography: United Kingdom
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• United Kingdom Blood Glucose Monitoring Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Self-monitoring Devices
• Continuous Blood Glucose Monitoring Devices

By End User
• Hospitals
• Home Care
• Diagnostic Centers

By Indication
• Diabetes
• Pregnancy
• Cardiovascular Disorders & Hypertension
• Cancer
• Respiratory Diseases
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Blood Glucose Monitoring Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.